 |
|
Computer simulation captures immune response to flu
May 19, 2009Goal: Adapt model to predict body's response to seasonal, bird and swine flu
Researchers have successfully tested first the first time a computer simulation of major portions of the body's immune reaction to influenza type A, with implications for treatment design and preparation ahead of future pandemics, according to work accepted for publication, and posted online, by the Journal of Virology. The new "global" flu model is built out of preexisting, smaller-scale models that capture in mathematical equations millions of simulated interactions between virtual immune cells and viruses.
Mathematical models and computer simulations have been used to understand viral infections and immune response to those infections, including influenza type A viruses, which can cause severe human disease. Type A flu viruses are classified by differing versions of key proteins, hemagglutinin (H) and neuraminidase (N), on their outer surfaces that attract attention by the human immune system, but that are always changing. Thus, some forms of both seasonal flu and swine flu are designated H1N1 because of their related, but differing surface proteins. The "bird flu" virus that emerged in 2004 is designated as H5N1. The newest, much-publicized strain of H1N1 swine flu is believed to have caused deaths and hospitalizations because victims' immune systems did not recognize the latest variations in these surface proteins. Each year, seasonal flu causes approximately 36,000 deaths in this country for the same reason.
A team of immunologists, mathematical modelers, statisticians and software developers created the new model over three years within the Center for Biodefense Immune Modeling at the University of Rochester Medical Center. The project was led by Hulin Wu, Ph.D., principal investigator of the project, director of the Center for Biodefense Immune Modeling (CBIM) and division chief of the Department of Biostatistics and Computational Biology, and by Martin S. Zand, M.D., Ph.D., co-director of the CBIM. The work was funded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, and the U.S. Department of Energy.
"High-speed, accurate computer simulation tools are urgently needed to dissect the relative importance of each attribute of viral strains in their ability to cause disease, and the contribution of each part of the immune system in a successful counterattack," said Zand. "Real world experiments simply cannot be executed fast enough to investigate so many complex surprises, and we must keep pace with viral evolution to reduce loss of life."
Small Window
The human immune system is composed of two major branches. The innate system provides immediate protection against bacteria, viruses and other microbes. The second aspect is the more time-consuming, precise and thorough adaptive immune system pumps out vast numbers of immune cells on the hope that one will have the right receptor protein to link up with, and become activated by, any invader encountered. When this occurs, the immune cell expands into an army of clones specifically selected to attack that organism. Workhorses of the adaptive system include "killer" T cells that attack cells that have been infected by viruses before the virus can turn them into virus factories, and helper T cells that orchestrate other parts of the immune response. Both types of T cells are spurred into action by antigen-presenting cells, which engulf the invading microbes and "show" them to the T cells so that the T cells can recognize the infection. In lymph nodes, helper T cells, in turn, cause the second major player in the adaptive response, the B cell, to start mass-producing antibodies, proteins that glom onto and eliminate them from the body.
The new model predicts how rapidly the T and B cells respond to influenza type A virus infection. For the purposes of the simulation, the model set aside the role of the innate immune system, but the researchers plan to add that aspect to future simulations. Depending on the pathogen at hand and a given patient's past exposure, either T cell or B cell responses may play a larger role in clearing the virus. One cell type may lead the immune counterattack in a person with a first-time infection, and another in a patient who has been infected before or vaccinated.
T cells partner with dendritic cells to make careful decisions about which key pieces of viruses will trigger a full-scale immune counterattack. Dendritic cells roam the body, checking each particle they come across for a self or invader "label." Upon encountering an invader, a dendritic cell will "swallow it," cut it up, and carry the pieces to the nearest lymph node. Once there, proteins inside the dendritic cell "present" protein fragments of the virus on the cell's surface for consideration by T cells gathered there. Once activated by high enough levels of target protein fragment, T cells become capable of destroying the virus.
Using a statistical method called sensitivity analysis, Wu, Zand and colleagues used the new model to compare the individual contribution of various immune cells to clear influenza from the body, including the presentation of fragments of pathogenic proteins on the surface of dendritic cells versus the action of helper and cell-killing T cells versus the direct glomming onto disease-related particles by antibodies. The model predicted that drugs and vaccines that change the presentation by dendritic cells of disease-related protein fragments (antigens) to T cells more strongly impact whether or not a given patient beats the flu than other immune factors in patients infected for the first time. Simulations also suggest that an increase in antigen presentation by dendritic cells can compensate for the increased infection rate of highly virulent influenza strains. Existing adjuvants - drugs that strengthen vaccines but have no effect alone - are available that enhance the ability of dendritic cells to present viral antigens to T cells.
Experiments on the effects of anti-viral drugs on a "flu-infected" virtual immune system also accurately predicted that lowering the viral load or spread within two days of symptoms enables rapid control of the infection. These results match known limitations of neuraminidase inhibitors like the widely stockpiled Tamiflu and Relenza, which inhibit viral reproduction in infected cells, but are only effective if given soon after infection. The model also predicted that antiviral therapies may be more effective if taken in combination, but only if administered within two days of infection. Unlike chronic HIV infection, the acute nature of influenza means there is a narrow time window during early infection when interfering with viral replication can reduce viral load.
"Heterosubtypic immunity" refers to the ability of human immune defenses primed to fight one strain of flu to provide broad protection should other strains of flu be encountered later. Whether or not a single vaccine can protect against any of the many H1N1 Influenza viruses would depend on this property. The team's model confirmed that heterosubtypic immunity to influenza depends on a specific quality, the number of killer T cells present in the lungs of a given individual at the start of infection. Thus, near-future vaccines against swine flu for instance may work better if designed to evoke local immune memory cells in the lungs, rather than administered through the bloodstream.
In addition, the model argues that a strong antibody response, along with local T cell expansion, will be important to ensure protection against future pandemics. The findings suggest that some unconventional therapies that rapidly boost immune responses might be effective in a worst case scenario of a pandemic influenza virus. One possibility is the treatment of those front line of the epidemic (e.g. healthcare workers) with an injection of the liquid portion of blood (serum) taken from patients who have previously been infected and successfully fought off an influenza virus. This serum would contain antibodies against the virus at hand. Current antiviral treatments only work if given with 48 hours of infection, and vaccines take several weeks to start working, leaving a gap that might be filled by immune sera injection.
Because its genetic makeup is new, little is known about the distribution of preexisiting immunity to current H1N1 "swine" flu across populations, the immune response to the virus or the efficacy of available vaccines. The team in Rochester hopes to contribute to the building of models that simulate swine flu infection across the entire U.S. population to better predict its course.
Along with Wu and Zand, major project contributors included Ha Youn Lee, Sung Yong Park, Jeanne Holden-Wiltse and Hongyu Miao in the Department of Biostatistics and Computational Biology at the Medical Center; David Topham, Joseph Hollenbaugh, Tim Mosmann and Brian Ward within the David H. Smith Center for Vaccine Biology & Immunology and the Department of Microbiology and Immunology; and John Treanor and Xia Jin in the Division of Infectious Diseases within the Department of Medicine. Alan Perelson led a partnering effort at the Los Alamos National Laboratory in New Mexico.
"The right computer model can provide a precise, hands-on way of measuring just how good our theories are about how the system responds to pandemic virus, and how to strengthen our defenses," said Wu.
University of Rochester Medical Center
A team of immunologists, mathematical modelers, statisticians and software developers created the new model over three years within the Center for Biodefense Immune Modeling at the University of Rochester Medical Center. The project was led by Hulin Wu, Ph.D., principal investigator of the project, director of the Center for Biodefense Immune Modeling (CBIM) and division chief of the Department of Biostatistics and Computational Biology, and by Martin S. Zand, M.D., Ph.D., co-director of the CBIM. The work was funded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, and the U.S. Department of Energy.
"High-speed, accurate computer simulation tools are urgently needed to dissect the relative importance of each attribute of viral strains in their ability to cause disease, and the contribution of each part of the immune system in a successful counterattack," said Zand. "Real world experiments simply cannot be executed fast enough to investigate so many complex surprises, and we must keep pace with viral evolution to reduce loss of life."
Small Window
The human immune system is composed of two major branches. The innate system provides immediate protection against bacteria, viruses and other microbes. The second aspect is the more time-consuming, precise and thorough adaptive immune system pumps out vast numbers of immune cells on the hope that one will have the right receptor protein to link up with, and become activated by, any invader encountered. When this occurs, the immune cell expands into an army of clones specifically selected to attack that organism. Workhorses of the adaptive system include "killer" T cells that attack cells that have been infected by viruses before the virus can turn them into virus factories, and helper T cells that orchestrate other parts of the immune response. Both types of T cells are spurred into action by antigen-presenting cells, which engulf the invading microbes and "show" them to the T cells so that the T cells can recognize the infection. In lymph nodes, helper T cells, in turn, cause the second major player in the adaptive response, the B cell, to start mass-producing antibodies, proteins that glom onto and eliminate them from the body.
The new model predicts how rapidly the T and B cells respond to influenza type A virus infection. For the purposes of the simulation, the model set aside the role of the innate immune system, but the researchers plan to add that aspect to future simulations. Depending on the pathogen at hand and a given patient's past exposure, either T cell or B cell responses may play a larger role in clearing the virus. One cell type may lead the immune counterattack in a person with a first-time infection, and another in a patient who has been infected before or vaccinated.
T cells partner with dendritic cells to make careful decisions about which key pieces of viruses will trigger a full-scale immune counterattack. Dendritic cells roam the body, checking each particle they come across for a self or invader "label." Upon encountering an invader, a dendritic cell will "swallow it," cut it up, and carry the pieces to the nearest lymph node. Once there, proteins inside the dendritic cell "present" protein fragments of the virus on the cell's surface for consideration by T cells gathered there. Once activated by high enough levels of target protein fragment, T cells become capable of destroying the virus.
Using a statistical method called sensitivity analysis, Wu, Zand and colleagues used the new model to compare the individual contribution of various immune cells to clear influenza from the body, including the presentation of fragments of pathogenic proteins on the surface of dendritic cells versus the action of helper and cell-killing T cells versus the direct glomming onto disease-related particles by antibodies. The model predicted that drugs and vaccines that change the presentation by dendritic cells of disease-related protein fragments (antigens) to T cells more strongly impact whether or not a given patient beats the flu than other immune factors in patients infected for the first time. Simulations also suggest that an increase in antigen presentation by dendritic cells can compensate for the increased infection rate of highly virulent influenza strains. Existing adjuvants - drugs that strengthen vaccines but have no effect alone - are available that enhance the ability of dendritic cells to present viral antigens to T cells.
Experiments on the effects of anti-viral drugs on a "flu-infected" virtual immune system also accurately predicted that lowering the viral load or spread within two days of symptoms enables rapid control of the infection. These results match known limitations of neuraminidase inhibitors like the widely stockpiled Tamiflu and Relenza, which inhibit viral reproduction in infected cells, but are only effective if given soon after infection. The model also predicted that antiviral therapies may be more effective if taken in combination, but only if administered within two days of infection. Unlike chronic HIV infection, the acute nature of influenza means there is a narrow time window during early infection when interfering with viral replication can reduce viral load.
"Heterosubtypic immunity" refers to the ability of human immune defenses primed to fight one strain of flu to provide broad protection should other strains of flu be encountered later. Whether or not a single vaccine can protect against any of the many H1N1 Influenza viruses would depend on this property. The team's model confirmed that heterosubtypic immunity to influenza depends on a specific quality, the number of killer T cells present in the lungs of a given individual at the start of infection. Thus, near-future vaccines against swine flu for instance may work better if designed to evoke local immune memory cells in the lungs, rather than administered through the bloodstream.
In addition, the model argues that a strong antibody response, along with local T cell expansion, will be important to ensure protection against future pandemics. The findings suggest that some unconventional therapies that rapidly boost immune responses might be effective in a worst case scenario of a pandemic influenza virus. One possibility is the treatment of those front line of the epidemic (e.g. healthcare workers) with an injection of the liquid portion of blood (serum) taken from patients who have previously been infected and successfully fought off an influenza virus. This serum would contain antibodies against the virus at hand. Current antiviral treatments only work if given with 48 hours of infection, and vaccines take several weeks to start working, leaving a gap that might be filled by immune sera injection.
Because its genetic makeup is new, little is known about the distribution of preexisiting immunity to current H1N1 "swine" flu across populations, the immune response to the virus or the efficacy of available vaccines. The team in Rochester hopes to contribute to the building of models that simulate swine flu infection across the entire U.S. population to better predict its course.
Along with Wu and Zand, major project contributors included Ha Youn Lee, Sung Yong Park, Jeanne Holden-Wiltse and Hongyu Miao in the Department of Biostatistics and Computational Biology at the Medical Center; David Topham, Joseph Hollenbaugh, Tim Mosmann and Brian Ward within the David H. Smith Center for Vaccine Biology & Immunology and the Department of Microbiology and Immunology; and John Treanor and Xia Jin in the Division of Infectious Diseases within the Department of Medicine. Alan Perelson led a partnering effort at the Los Alamos National Laboratory in New Mexico.
"The right computer model can provide a precise, hands-on way of measuring just how good our theories are about how the system responds to pandemic virus, and how to strengthen our defenses," said Wu.
University of Rochester Medical Center
Immune System Current Events and Immune System News RSSFirst use of antibody and stem cell transplantation to successfully treat advanced leukemia
For the first time, researchers at Fred Hutchinson Cancer Research Center have reported the use of a radiolabeled antibody to deliver targeted doses of radiation, followed by a stem cell transplant, to successfully treat a group of leukemia and pre-leukemia patients for whom there previously had been no other curative treatment options.
New Synthetic Molecules Trigger Immune Response to HIV and Prostate Cancer
Researchers at Yale University have developed synthetic molecules capable of enhancing the body's immune response to HIV and HIV-infected cells, as well as to prostate cancer cells. Their findings, published online in the Journal of the American Chemical Society, could lead to novel therapeutic approaches for these diseases.
Common Pain Relievers May Dilute Power of Flu Shots
With flu vaccination season in full swing, research from the University of Rochester Medical Center cautions that use of many common pain killers - Advil, Tylenol, aspirin - at the time of injection may blunt the effect of the shot and have a negative effect on the immune system.
American Dietetic Association Releases Updated Position Paper Promoting and Supporting Breastfeeding
The American Dietetic Association has released an updated position paper on breastfeeding that details health benefits for both infants and mothers and encourages promotion of breastfeeding whenever possible.
Daily dose of color may boost immunity this flu season
Hoping to keep the flu at bay? A strong immune system helps. Enjoying the bounty of colorful fruits and vegetables available right now can be an important step toward supporting your family's immune system this cold/flu season.
Immune therapy can protect against or treat later lymphoma
Specially developed immune system cells that target the common Epstein-Barr virus can protect immune-suppressed bone marrow transplant recipients against lymph system disease and cancers that arise from the viral infection.
PATH Malaria Vaccine Initiative shares strategy for developing 'next-generation' malaria vaccines
Marking its tenth anniversary year, the PATH Malaria Vaccine Initiative (MVI) today unveiled a new strategy that sets the stage for an aggressive push targeting the long-term goal of eliminating and eradicating malaria. Malaria is one of the world's deadliest infectious diseases, killing nearly 900,000 people a year, most of them children in sub-Saharan Africa.
Study reveals a 'missing link' in immune response to disease
The immune system's T cells have the unique responsibilities of being both jury and executioner. They examine other cells for signs of disease, including cancers or infections, and, if such evidence is found, rid them from the body. Precisely how T cells shift so swiftly from one role to another, however, has been a mystery.
Smokers with common autoimmune disorder at higher risk for skin damage
As if there weren't enough reasons to stop smoking, a team of researchers at the Research Institute of the McGill University Health Centre (RI-MUHC) have just found another.
Breakthrough in fight against Hendra virus
There has been a breakthrough in the fight against the deadly Hendra virus following the development of a treatment which shows great potential to save the lives of people who become infected with the virus.
More Immune System Current Events and Immune System News Articles
 |
The Immune System 3e by Peter Parham (Author) The Immune System, Third Edition emphasizes the human immune system and synthesizes immunological concepts into a comprehensible, up-to-date, and reader-friendly account of how the immune system works. Written for undergraduate, medical, dental, and pharmacy students in immunology courses, it makes generous use of medical examples to illustrate points. The Third Edition has been extensively revised and updated and includes two new chapters on innate and adaptive immunity, which explore the physical, cellular, and molecular principles underlying these responses to infection. It also features enhanced coverage of aspects of innate immunity such as the complement system, Toll-like receptors, defensins, and C-reactive protein; the role of dendritic cells... |
 |
How the Immune System Works (Blackwell's How It Works) by Lauren M. Sompayrac (Author) Understanding the immune system is crucial for both medical and bioscience students, with new research revealing yet more secrets year on year. Many books offer in-depth introductions to the subject, but How the Immune System Works remains uniquely popular for its personable and practical overview of the nuts and bolts of the immune system. This third edition provides a perfect introduction to the essential principles of the immune system, covered in humorous but highly informative 'lectures' accompanied by clear and accessible illustrations. It is perfect for exam preparation or as an enjoyable overview of a difficult subject. Both students and instructors will welcome the clarity and authority that Lauren Sompayrac brings to this timely revision. |
 |
The Immune System Cure: Optimize Your Immune System in 30 Days-The Natural Way! by Kensington (Producer) What causes one person to catch a cold or flu and another to avoid it? Why do serious outbreaks of infectious diseases leave some individuals untouched? What allows someone to be incapacitated by allergies? The answer lies within nature itself-our immune system. The Immune System Cure provides simple techniques for supercharging your immune system to resist and prevent disease. Through diet, exercise, stress reduction and nutritional supplements, including plant sterols and sterolins, you can harness the power of your immune system in just 30 days and help it combat: Antibiotic-resistant bacteria Fibromyalgia Allergies Hepatitis C Tuberculosis Cancer Rheumatoid arthritis and other autoimmune diseases Chronic fatigue syndrome and more Now you can maintain a healthy... |
 |
The Immune System by Peter Parham (Author) The Immune System, Second Edition has been designed for use in immunology courses for undergraduate, medical, dental, and pharmacy students. This class-tested and successful textbook synthesizes the established facts of immunology into a comprehensible, coherent, and up-to-date account of how the immune system works, rather than presenting immunology as a chronology of experiments and discoveries. Emphasizing the human immune system the text has been designed to break down the barriers which often divide basic and clinical immunology. The reader-friendly text, section and chapter summaries, and full-color illustrations make the book accessible and easily understandable to students. The Immune System is adapted from Immunobiology by Janeway, Travers & Walport. New in... |
 |
90-Day Immune System Makeover by Janet C. Maccaro (Author) No matter how your health has been in the past, there is something you can do right now—a complete makeover to give you the vitality and energy to embrace life at your best! In just ninety days, Janet Maccaro will enable you to build and strengthen your immune system to bring your body into proper balance and experience disease-free living. Birthed out of Maccaro’s twenty-year struggle with poor health and immune dysfunction, this book provides time-tested natural alternatives to strengthen your body, mind, and spirit. If you’re tired of being sick and tired, and if you’re ready for a complete immune system makeover, this easy-to-follow guide to renewed health can show you how! |
 |
In Defense of Self: How the Immune System Really Works by William R. Clark (Author) We live in a sea of seething microbial predators, an infinity of invisible and invasive microorganisms capable of setting up shop inside us and sending us to an early grave. The only thing keeping them out? The immune system. William Clark's In Defense of Self offers a refreshingly accessible tour of the immune system, putting in layman's terms essential information that has been for too long the exclusive province of trained specialists. Clark explains how the immune system works by using powerful genetic, chemical, and cellular weapons to protect us from the vast majority of disease-causing microbes-bacteria, viruses, molds, and parasites. Only those microbes our bodies need to help us digest food and process vitamins are admitted. But this same system can endanger us by... |
 |
The Top 100 Immunity Boosters: 100 Recipes to Keep Your Immune System Fighting Fit by Charlotte Haigh (Author) Eat well today for a healthier tomorrow! With proper nutrition, we can actually bolster our immune system—and, as these 100 recipes prove, it’s not only easy to do, it’s also delicious. Here are foods rich in important vitamins, such as A, B complex, C, and E; in minerals, including zinc, selenium, and calcium; in Omega-3 and -6 fatty acids; and in protein and fiber. For each choice, there’s a tasty recipe, and information on its beneficial nutrients. Enjoy a sweet potato summer salad (with lots of betacarotene); cholesterol-lowering guacamole; broccoli stir-fry (a potential cancer-fighter); and a tasty blueberry smoothie. An ailment directory makes it simple to locate the right food for any problem. |
 |
Immunitril (90 Caps) - The Worlds Strongest Immune System Booster!! ***50% MORE*** by Optimal Therapeutics Immunitril Activate Immune Cells "The Body's First Line of Defense" Immunitril is the most complete immunity support formula available today. This revolutionary complex is a unique combination of herbs, extracts, minerals, and anti-oxidant vitamins providing maximum support for immune system function. The Best Treatment For an Illness is to Stop It Before it Starts! Immunitril's Many Benefits: Promotes Healthy Immune System Function Increases Healthy Digestive Microflora Supports the Function of White Blood Cells Anti-oxidant Protection Against Cellular Damage May Be Used Daily or When You Feel Your Immunity May Be At Risk Immunitril Contains All Of the Most Powerful Immune System Enhancing Ingredients! Ester C -The patented and improved form of Vitamin C Vitamin E -a powerful... |
 |
Maximum Healing: Improve Your Immune System and Optimize Your Natural Ability to Heal by H. Robert Silverstein (Author), Tom Monte (Author) If you suffer from—allergies, asthma, high blood pressure or cholesterol, cancer, chronic fatigue, headaches, heart disease, joint pain, skin disorder, or rheumatoid arthritis—then this may be the most important book you will ever read. Inspiring case histories demonstrate successful treatment and prevention of these and many other illnesses. |
 |
Boost Your Immune System Naturally: A Lifestyle Action Plan for Strengthening Your Natural Defences by Beth MacEoin (Author) Today many of us are faced with extremely high levels of pollution, allergens, and other threats to our health in the form of certain strains of bacteria that are immune to antibiotics. Boost Your Immune System Naturally shows you how to improve your overall health to ward off illness and keep you in optimal health. Written by an expert in nutrition and naturopathy, these easy-to-follow diet, lifestyle and supplement plans provide a totally natural way to strengthen your natural defenses. |
| © 2009 BrightSurf.com |